Apoptosis and Molecular Targeting Therapy in Cancer
Apoptosis is the programmed cell death which maintains the healthy survival/death balance in metazoan cells. Defect in apoptosis can cause cancer or autoimmunity, while enhanced apoptosis may cause degenerative diseases. The apoptotic signals contribute into safeguarding the genomic integrity while...
Main Authors: | Mohamed Hassan, Hidemichi Watari, Ali AbuAlmaaty, Yusuke Ohba, Noriaki Sakuragi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/150845 |
Similar Items
-
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
by: Hassan Mohamed K, et al.
Published: (2011-12-01) -
Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection.
by: Mohamed K Hassan, et al.
Published: (2014-01-01) -
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
by: Sudo Satoko, et al.
Published: (2011-08-01) -
Emerging Therapeutic Biomarkers in Endometrial Cancer
by: Peixin Dong, et al.
Published: (2013-01-01) -
Retracted: Apoptosis and Molecular Targeting Therapy in Cancer
by: BioMed Research International
Published: (2020-01-01)